HealthQuill Chest Pain
Rein Therapeutics, Inc. has paused its enrollment and patient dosing at its US clinical trial sites testing a lung disease drug, after the regulator placed the experiment on clinical hold. 
Drugs Health Pharma

Rein Therapeutics’ trial drug for lung disease disorder put on clinical hold

HQ Team July 13, 2025: Rein Therapeutics, Inc., has paused its enrollment and patient dosing at its US clinical trial sites testing a.

Read More
The US regulator, the Food and Drug Administration, has approved Winrevair therapy of Merck & Co., Inc., to treat pulmonary arterial hypertension.
Drugs Health Pharma

US regulator clears Merck’s lung therapy after ‘significant’ results

 HQ Team March 27, 2024: The US regulator, the Food and Drug Administration, has approved Winrevair therapy of Merck & Co., Inc., to.

Read More